On 20 August 2019, on request of the applicant, the Czech competent authority clarified that not all antidotes listed in the product assessment report have to be available and that the availability of any of the antidotes listed in the product assessment report sufficed to fulfil the requirements set for granting the authorisation. This clarification was acknowledged by the Hungarian competent authority.
Recital 7, Decision_act (EU) 2024/2420
In forcesince 13 Sep 2024